Search - tctmd.com

Displaying 61 - 72 of 72

Sort: Relevancy | Date

News Daily News

BARI 2D：改善 2 型糖尿病患者的危险因素控制情况可以提高其生存率

Yael L. Maxwell

August 12, 2015

Presentation TCT 2014

The Case for Medical Therapy without Revascularization in Most Patients with and without Diabetes

Presenter: George D. Dangas, Michael E. Farkouh, David J. Maron

September 16, 2014

Presentation TCT 2014

Wheres the Data for Any of This? Medical Therapy First Is Most Appropriate!

Presenter: Ajay J. Kirtane, David Taggart, David J. Maron

September 15, 2014

Presentation TCT 2013

The Decision to Revascularize Must Be Made on the Background of Improving Medical Therapies and Life Style Modification, with Greater Longevity

Presenter: David Maron

October 29, 2013

Presentation TCT 2013

Risk/Benefit Favors: Medical Therapy First

Presenter: David Maron

October 28, 2013

Presentation TCT 2013

Rationale, Design and Status of the ISCHEMIA Trial

Presenter: David Maron

October 28, 2013

News Daily News

Ischemia-Based Treatment Does Not Alter Mortality in Postrevascularization Patients

Jason Kahn

April 12, 2013

News Daily News

El Tratamiento basado en la Isquemia No Altera la Mortalidad en Pacientes Postrevascularizados

Jason Kahn

April 12, 2013

Presentation TCT 2012

Design and Rationale of ISCHEMIA

Presenter: David Maron

October 24, 2012

Presentation TCT 2012

Assessment: Clinical Cardiologist

Presenter: David Maron

October 22, 2012

News Daily News

Subestudio COURAGE: Debe Tratarse cada Elemento, No el Síndrome en su Conjunto

March 06, 2012

News Daily News

COURAGE Substudy: Treat the Components, Not the Syndrome

March 06, 2012

Advertisement

BARI 2D：改善 2 型糖尿病患者的危险因素控制情况可以提高其生存率

The Case for Medical Therapy without Revascularization in Most Patients with and without Diabetes

Wheres the Data for Any of This? Medical Therapy First Is Most Appropriate!

The Decision to Revascularize Must Be Made on the Background of Improving Medical Therapies and Life Style Modification, with Greater Longevity

Risk/Benefit Favors: Medical Therapy First

Rationale, Design and Status of the ISCHEMIA Trial

Ischemia-Based Treatment Does Not Alter Mortality in Postrevascularization Patients

El Tratamiento basado en la Isquemia No Altera la Mortalidad en Pacientes Postrevascularizados

Design and Rationale of ISCHEMIA

Assessment: Clinical Cardiologist

Subestudio COURAGE: Debe Tratarse cada Elemento, No el Síndrome en su Conjunto

COURAGE Substudy: Treat the Components, Not the Syndrome

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content